SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-043870
Filing Date
2023-12-06
Accepted
2023-12-06 16:05:38
Documents
12
Period of Report
2023-12-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37218
  Complete submission text file 0001493152-23-043870.txt   207410

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE rtgn-20231204.xsd EX-101.SCH 3027
3 XBRL LABEL FILE rtgn-20231204_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE rtgn-20231204_pre.xml EX-101.PRE 22367
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3147
Mailing Address 1450 NORTH MCDOWELL BOULEVARD SUITE 150 PETALUMA CA 94954
Business Address 1450 NORTH MCDOWELL BOULEVARD SUITE 150 PETALUMA CA 94954 415-578-9583
RetinalGenix Technologies Inc. (Filer) CIK: 0001836295 (see all company filings)

IRS No.: 823936890 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-258528 | Film No.: 231469654
SIC: 3841 Surgical & Medical Instruments & Apparatus
Industrial Applications and Services